SCHEMBL4896903

SCHEMBL4896903

O=C(CCCCCN1C(=O)c2ccccc2Oc2ccc(Cl)cc21)NO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 19/20 1.00
HDAC3 O15379 16/20 1.00
HDAC4 P56524 16/20 1.00
HDAC1 Q13547 16/20 1.00
HDAC7 Q8WUI4 16/20 1.00
HDAC2 Q92769 16/20 1.00
HDAC10 Q969S8 16/20 1.00
HDAC11 Q96DB2 16/20 1.00
HDAC6 Q9UBN7 16/20 1.00
HDAC9 Q9UKV0 16/20 1.00
HDAC5 Q9UQL6 16/20 1.00
TUBB4A P04350 10/20 1.00
TUBB P07437 10/20 1.00
TUBA3C P0DPH7 10/20 1.00
TUBA1B P68363 10/20 1.00
TUBA4A P68366 10/20 1.00
TUBB4B P68371 10/20 1.00
TUBB3 Q13509 10/20 1.00
TUBB2A Q13885 10/20 1.00
TUBB8 Q3ZCM7 10/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2144150 0.88 HDAC8 (1.00) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL2143790 0.88 HDAC8 (1.00) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL1367877 0.88 HDAC8 (1.00) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL4886993 0.85 HDAC8 (1.00) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL4896867 0.80 HDAC8 (1.00) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL4899333 0.80 HDAC8 (1.00) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL4896687 0.79 HDAC8 (1.00) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL17425318 0.76 HDAC8 (0.77) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL30304758 0.76 HDAC8 (1.00) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL14862921 0.76 HDAC8 (1.00) HDAC8HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275023-A1 N-Hydroxyamides Omege-Substituted with Tricyclic Groups as Histone Deacetylase Inhibitors, Their Preparation and Use in Pharmaceutical Formulations MENARIN INTERNATIONAL OPERATIONS LUXEMBOURG S.A. (LU) 2008-11-06 US claimed
US-20080275023-A1 N-Hydroxyamides Omege-Substituted with Tricyclic Groups as Histone Deacetylase Inhibitors, Their Preparation and Use in Pharmaceutical Formulations MENARIN INTERNATIONAL OPERATIONS LUXEMBOURG S.A. (LU) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275023-A1 N-Hydroxyamides Omege-Substituted with Tricyclic Groups as Histone Deacetylase Inhibitors, Their Preparation and Use in Pharmaceutical Formulations HDAC8, HDAC2, HDAC7 HDAC8 1/4885HDAC3 5/4885HDAC4 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.